Endpoint Management™ in application to Photo-thermal Stimulation of the Retina Recognized for Contribution to Field of BioMedical Optics. Read more.
Maximizing outcomes of treatment for retinal vascular disease.
A Retina Today Supplement on Endpoint Management. Read more.
PASCAL® Synthesis™ Receives FDA 510(k) Clearance. Read More.
Professor Paolo Stanga discusses his use of PASCAL lasers and Endpoint Management. Watch Video
Topcon Medical Laser Systems (TMLS) the global leader in providing physicians with premiere ophthalmic laser scanning solutions. TMLS is dedicated to working with ophthalmologists to evolve standards of care which provide significant benefits to both physicians and patients.
Located in Santa Clara, California the company was founded in January 2004 to develop a radically new technology for the treatment of ocular disease. Initially developed at Stanford University, and exclusively licensed to TMLS, the PASCAL® Method of Photocoagulation is used to treat a variety of retinal conditions including diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusive disease. PASCAL Photocoagulators provides significantly improved performance for the physician and an enhanced therapeutic…Learn More